ScholarIQanswers from OpenAlex

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

PaperCitations, authors & open-access status

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome have?

ScholarIQcitation count

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome has 1,682 citations in the OpenAlex counts ScholarIQ stores.

When was Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome published?

ScholarIQyear

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome has 2017 year in the ScholarIQ index.

What is the open-access status of Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome?

ScholarIQoa status

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome has bronze oa status in the ScholarIQ index.

What is the DOI of Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome?

ScholarIQdoi

The DOI for Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome is on the source record.

What is the PMID of Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome?

ScholarIQpmid

The PMID for Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome is on the source record.

What is the OpenAlex record for Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome?

ScholarIQopenalex

The OpenAlex for Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial